MTOR and kidney cancer: Comprehensive characterization of the regulation of gene expression by the HIF–VHL and mTOR pathways is crucial to understanding the biology of VHL-defective kidney cancer, particularly as agents targeting both these pathways are being deployed therapeutically15,16.